There was a significant association between glioma grading and IDH1/2 (p < 0.05), 1p/19q (p < 0.05), MGMT (p < 0.05), Ki67 (p < 0.01), and MAGED2 (p < 0.01). The gene discussed is MAGED2; the disease is central nervous system cancer.